查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467567

2024-2032 年按產品、流程類型、產品類型、應用、最終用戶和地區分類的心室輔助裝置市場報告

Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球心室輔助裝置市場規模達到 19 億美元。心臟衰竭的盛行率不斷上升、捐贈心臟的供應有限、支持性監管框架和更快的批准、VAD 植入手術技術的改進以及技術進步是推動市場發展的一些關鍵因素。

心室輔助裝置 (VAD) 是一種醫療裝置，旨在支持衰弱或衰竭的心臟功能。它們主要用作患者等待心臟移植時的臨時措施，或作為不適合移植的患者的長期解決方案。 VAD 透過手術植入，幫助將血液從心室泵送到身體的其他部位。這些設備由通常放置在患者腹部或胸部的幫浦和將幫浦連接到外部電源的傳動系統組成。幫浦負責接管心臟的泵血作用，確保血液在全身充分循環。它們可以幫助緩解症狀，包括疲勞、呼吸急促和體液滯留。此外，VAD 可以作為移植的橋樑，保持患者穩定並提高他們接受捐贈心臟的機會。因此，VAD 徹底改變了心臟衰竭的治療方法，為患者提供了更好的生活品質、更高的能量水平和更高的生存率。

心血管疾病（CVD）盛行率的上升是推動市場成長的關鍵因素之一。除此之外，醫療保健專業人員和患者對 VAD 療法的益處和可用性的認知不斷增強，也有助於市場的擴張。對醫療保健提供者、患者和護理人員進行有關 VAD 治療心臟衰竭有效性的教育的力度不斷加大，導致這些設備的接受度和採用率不斷提高。此外，支持性的監管框架和批准也促進了 VAD 的商業化和採用。世界各地的監管機構一直積極參與簡化核准流程、確保安全並促進 VAD 技術創新。這種有利的監管環境鼓勵製造商投資研發 (R&D) 並引入先進的 VAD。此外，VAD 植入手術技術的進步使得手術更安全、更容易進行。開胸手術或肋下切口等微創手術方法的引入，減少了手術創傷，縮短了恢復時間，並擴大了患者接受 VAD 治療的資格，從而加速了 VAD 的採用。此外，醫療保健支出的增加，特別是在新興經濟體，也促進了 VAD 市場的成長。其他因素，包括顯著的經濟成長、改善的醫療基礎設施、政府為改善醫療服務而採取的有利舉措，以及患者投資新的心臟衰竭治療方案的意願不斷增強，預計也將刺激市場成長。

心室輔助裝置市場趨勢/促進因素：

心臟衰竭盛行率增加

全球心臟衰竭盛行率的不斷上升是推動心室輔助裝置市場的重要因素。心臟衰竭病例的增加可歸因於人口老化、個人久坐的生活方式、肥胖以及糖尿病和高血壓等慢性疾病的增加。心臟衰竭的風險隨著年齡的成長而增加，老年人更有可能需要機械循環支持。人口老化，特別是在已開發國家，為 VAD 創造了巨大的患者庫，推動了市場的成長。隨著心臟衰竭患者數量的持續成長，對 VAD 作為可行治療選擇的需求也在增加。 VAD 為可能對傳統療法沒有充分反應的晚期心臟衰竭患者提供了解決方案，提供機械支持並改善他們的生活品質。

捐贈心臟的供應有限

適合移植的供體心臟的稀缺性是推動市場成長的另一個關鍵因素。心臟移植仍然是治療末期心臟衰竭的黃金標準。然而，可用的捐贈心臟數量遠低於需求。由於 VAD 充當移植的橋樑，可保持患者穩定並提高接受捐贈心臟的機會，因此它們擴大被用作不適合移植的患者的長期解決方案。因此，合適的心臟捐贈者的有限性產生了對心臟移植替代品的需求，例如 VAD，預計這將進一步推動預測期內市場的成長。

科技進步的崛起

VAD 技術的快速進步極大地促進了市場的成長。主要參與者的持續研發 (R&D) 努力導致了設備尺寸更小、耐用性提高、控制系統增強以及患者治療效果更好。這些技術進步將 VAD 的使用範圍擴大到了更廣泛的患者群體，包括體型較小的患者或患有心臟衰竭的兒童。此外，設備設計和植入技術的進步降低了併發症的風險，提高了設備的可靠性，並提高了患者的舒適度。 VAD 技術的此類創新和改進促進了創新設備的開發，這些設備更有效率、更安全，對醫療保健專業人員和患者都有吸引力，從而支持市場成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球心室輔助裝置市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 左心室輔助裝置 (LVAD)
    • 市場走向
    • 市場預測
  • 右心室輔助裝置 (RVAD)
    • 市場走向
    • 市場預測
  • 雙心室輔助裝置 (BiVAD)
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按流量類型

  • 脈動流
    • 市場走向
    • 市場預測
  • 非脈動或連續流
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依產品類型

  • 植入式心室輔助裝置
    • 市場走向
    • 市場預測
  • 非植入性心室輔助裝置
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 移植橋 (BTT) 療法
    • 市場走向
    • 市場預測
  • 目的地治療
    • 市場走向
    • 市場預測
  • 通往復甦的橋樑和通往候選的橋樑
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依最終用戶

  • 門診手術中心
    • 市場走向
    • 市場預測
  • 醫院
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格指標

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH (Syscore GmbH)
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc. (LivaNova PLC)
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH (Getinge)
    • Medtronic Inc.
    • Syncardia Systems LLC (Versa Capital Management LLC)
    • TandemLife (LivaNova Plc)
    • Terumo Corporation
Product Code: SR112024A2276

The global ventricular assist devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 8.5% during 2024-2032. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.

Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.

A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.

Ventricular Assist Devices Market Trends/Drivers:

Increase in the prevalence of heart failure

The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.

Limited availability of donor hearts

The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.

Rise in technological advancements

Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.

Ventricular Assist Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global ventricular assist devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, flow type, product type, application, and end user.

Breakup by Product:

Left Ventricular Assist Device (LVAD)

Right Ventricular Assist Device (RVAD)

Biventricular Assist Device (BiVAD)

Others

Left ventricular assist device (LVAD) represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes left ventricular assist device (LVAD), right ventricular assist device (RVAD), biventricular assist device (BiVAD), and others. According to the report, left ventricular assist device (LVAD) represented the largest segment.

Breakup by Flow Type:

Pulsatile Flow

Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market

The report has provided a detailed breakup and analysis of the market based on the flow type. This includes pulsatile flow and non-pulsatile or continuous flow. According to the report, non-pulsatile or continuous flow represented the largest segment.

Breakup by Product Type:

Implantable Ventricular Assist Devices

Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices represent the largest product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable ventricular assist devices and non-implantable ventricular assist devices. According to the report, implantable ventricular assist devices represented the largest segment.

Breakup by Application:

Bridge-to-Transplant (BTT) Therapy

Destination Therapy

Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant (BTT) therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes bridge-to-transplant (BTT) therapy, destination therapy, and bridge to recovery and bridge to candidacy. According to the report, bridge-to-transplant (BTT) therapy represented the largest segment.

Breakup by End User:

Ambulatory Surgery Centers

Hospital

Others

Hospital holds the leading position in the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes ambulatory surgery centers, hospital, and others. According to the report, hospital represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Abiomed Inc.

Berlin Heart GmbH (Syscore GmbH)

Bivacor Inc.

Calon Cardio

Cardiacassist Inc. (LivaNova PLC)

CHF Solutions Inc.

Jarvik Heart Inc.

MAQUET GmbH (Getinge)

Medtronic Inc.

Syncardia Systems LLC (Versa Capital Management LLC)

TandemLife (LivaNova PLC)

Terumo Corporation

Key Questions Answered in This Report

  • 1. How big is the global ventricular assist devices market?
  • 2. What is the expected growth rate of the global ventricular assist devices market during 2024-2032?
  • 3. What are the key factors driving the global ventricular assist devices market?
  • 4. What has been the impact of COVID-19 on the global ventricular assist devices market?
  • 5. What is the breakup of the global ventricular assist devices market based on the product?
  • 6. What is the breakup of the global ventricular assist devices market based on the flow type?
  • 7. What is the breakup of the global ventricular assist devices market based on the product type?
  • 8. What is the breakup of the global ventricular assist devices market based on the application?
  • 9. What is the breakup of the global ventricular assist devices market based on the end-user?
  • 10. What are the key regions in the global ventricular assist devices market?
  • 11. Who are the key players/companies in the global ventricular assist devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2023
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2023
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2024-2032
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players